Morgan Stanley’s BiomX PHGE Stock Holding History

Morgan Stanley’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71.7K	Buy	+19,100	New	+$90.1K	﹤0.01%	6286
2025 Q3	–	Sell	-97,581	Closed	-$834K	–	8312
2025 Q2	$834K	Buy	+97,581	New	+$974K	﹤0.01%	5201
2022 Q1	–	Sell	-21	Closed	-$6K	–	8078
2021 Q4	$6K	Buy	21 +10	+91%	+$4K	﹤0.01%	7606
2021 Q3	$6K	Hold	11	–	–	﹤0.01%	7454
2021 Q2	$11K	Hold	11	–	–	﹤0.01%	7208
2021 Q1	$14K	Buy	+11	New	+$14.9K	﹤0.01%	6845

Other funds holding PHGE

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Morgan Stanley's PHGE Position: Q1 2026 in Review

Morgan Stanley opened a new position in BiomX (PHGE) in Q1 2026: 19,100 shares worth $71.7K. The stake represents ﹤0.01% of the portfolio and ranks #6286 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in PHGE as recently as Q2 2025.

Morgan Stanley first reported a position in PHGE in Q1 2021 and has held it in 6 quarters since. The position peaked at $834K in Q2 2025. 13 funds tracked by Wall St. Rank hold PHGE as of Q1 2026.

Morgan Stanley held 19,100 shares of BiomX worth $71.7K as of Q1 2026.
BiomX was a new Morgan Stanley position in Q1 2026.
BiomX made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6286 holding.
Morgan Stanley first reported a position in BiomX in Q1 2021 and has held it in 6 quarters since.
Morgan Stanley's BiomX position peaked at $834K in Q2 2025.
13 funds tracked by Wall St. Rank held BiomX as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.